Alzheimers
NeurologyLive: The Study Design Behind P-tau217 Rule-In Performance
August 3, 2026Author(s)Yogesh Shah, MD, MPH, FAAFP Dr. Yogesh Shah, MD, reviews the evidence supporting P-tau217 as a reliable rule-in biomarker for Alzheimer’s pathology and discusses how clinicians can incorporate blood-based testing into patient evaluation.As blood-based biomarkers move closer to routine clinical use, demonstrating agreement with established diagnostic standards remains essential. For Alzheimer disease (AD), […]
Central Florida Public Media: Central Florida seniors learned practical ways to support cognitive wellness through exercise, social engagement, and learning.
Residents of the College Park Towers Senior Apartments in Orlando gathered Wednesday for Bilingual Activ8 Your Brain Bingo, an event designed to promote brain health through fun, interactive activities. The nonprofit Global Alzheimer’s Platform Foundation partnered with Conquest Research to offer brain health education and free cognitive screenings. Engage speaks with participants and organizers about simple habits that can help […]
ALZForum: PrevenTRON and Beyond
24 Jul 2026 Part 2 of 2No, they are not Optimus Jr, Megatron’s clones, or any other new, amyloid-shattering members of the Tron family franchise of transformer robots, though perhaps Roche does not mind if you think so for a moment. Rather, the TRONTIER twins are currently enrolling Phase 3 trials for early AD, and […]
PR Newswire: Cumulus Neuroscience Presents Data at AAIC 2026 Annual Meeting Showing a Two-Minute Digital Task Matches or Outperforms Clinical Benchmarks for Alzheimer’s Trial Pre-enrichment
Across three independent studies, the NeuLogiq® Platform two-minute tablet-based Symbol Swap task delivered clinically meaningful discrimination between control, MCI and Alzheimer’s dementia groups and detected blood-biomarker-defined pathology — including in clinically normal individuals — with accuracy matching or exceeding the ADAS-Cog, MoCA and MMSE benchmarks. LONDON, July 15, 2026 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global […]
Tech Times: Tablet Task Beats Alzheimer’s Clinical Tests in Two Minutes, AAIC Data Show
Symbol Swap matched or exceeded ADAS-Cog, MoCA, and MMSE across three independent studiesBy Henry BakerPublished: Jul 15 2026, 3:39 PM EDT On the final day of the world’s largest dementia research conference, a startup presented data Wednesday suggesting that a two-minute tablet task can do what a trained clinician typically takes 10 to 45 minutes to […]
Breaking Barriers: New Findings on Biomarkers and Expanding Participation in Alzheimer’s Research
GAP Experts Share Poster Presentations at Alzheimer’s Association International Conference (AAIC) Washington D.C., July 9, 2026- The Global Alzheimer’s Platform Foundation®, (GAP) will have two poster presentations at the 2026 Alzheimer’s Association International Conference (AAIC) being held in Londong July 12 through July 15. All posters are in the Exhibit Hall in Excel London, Royal Victoria Dock, 1 […]
Norway Sun: “Global Study Develops Convenient Blood Test for Alzheimer’s”
By:Ingrid Johansen, Date: July 7, 2026 A significant global research initiative is underway to develop a convenient blood test for diagnosing Alzheimer’s disease. The study focuses on three specific proteins linked to the condition, aiming to compare the efficacy of the test with current brain scans. If successful, this new test could offer a simpler […]
GAP Applauds the Decision by Elevance Health to Explicitly Endorse the Use of Blood-Based Biomarker Testing
Washington D.C., July 1, 2026- Elevance Health, formerly Anthem Inc., updated their medical policy, to allow for blood-based biomarker testing for the detection and diagnosis of Alzheimer’s disease, making Elevance Health one of the first major payors to outline coverage criteria. GAP President John Dwyer said, “GAP applauds the decision by Elevance Health to explicitly endorse […]
TrialSite News: Exploring Circular RNA Biomarkers in Alzheimer’s Research
John Dwyer, the President of the Global Alzheimer’s Platform Foundation (GAP) joins TrialSiteNews to discuss a collaboration and partnership with Circular Genomics. The partnership will analyze blood test samples to investigate the potential for circular RNA biomarkers to assist in the diagnosis & treatment of Alzheimer’s Disease. Topics covered: Press Release: https://globalalzplatform.org/2026/05…
Tampa Bay Times/MSN: Alzheimer’s Association’s Florida Gulf Coast chapter raises $780,000 at gala
Story by Amy Scherzer, Bay Correspondent Tearful yet joyful, the annual Inspire, Imagine & Hope Gala honored Tampa neurologist Dr. Susan Steen for her 40-plus years advancing brain health education and leading clinical trials for Alzheimer’s disease, Parkinson’s disease and multiple sclerosis. Gala co-chairs Lyle Fogarty and Dr. Shannon Moroney shared the personal impact of […]